The FSUE Moscow Endocrine Plant signed a cooperation agreement with the FSBI National Medical Research Centre of Endocrinology of the Ministry of Health of the Russian Federation.
The agreement will allow to combine the competences, scientific and production capabilities of the parties in the development and introduction of defective medicines to the market, including their clinical trials, putting into production and increasing of the availability of endocrinological drugs in demand in the Russian Federation.
Discussion of topical issues and prospects for the implementation of cooperation took place within the framework of a working meeting between the management of ENDOPHARM and the National Medical Research Centre of Endocrinology at the production site of the Moscow Endocrine Plant.
Representatives of the National Medical Research Centre of Endocrinology got acquainted with a wide range of capabilities of the Moscow Endocrine Plant, noting the high level of production culture, technical equipment of laboratories and workshops, qualifications of the enterprise personnel.
“We deal with certain objective problems of some medicines shortage in pediatric endocrinology and a number of other medicines in which our Centre is very interested. We set great hopes upon cooperation with ENDOPHARM”- summed up Galina Melnichenko, the Academician of the Russian Academy of Sciences, the Deputy Director of the National Research Centre of Endocrinology for Research.
As a result of the meeting, the parties reached specific agreements on plans for interaction and details of the cooperation implementation.
Enhancing of Cooperation in Development of Endocrinological Drug Products
5 April 2021
Comment type is not specified in the component properties.